Special Populations
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 131 Shown
  • Clinical Impact of New Data From IAS 2017

    In this downloadable slideset, expert faculty members Anton L. Pozniak, MD, FRCP, and Kathleen E. Squires, MD, summarize key studies from the IAS 2017 conference.
    Date Posted: 8/9/2017
  • Key Studies Influencing My Practice Following IAS 2017

    Anton L. Pozniak, MD, FRCP, provides a rapid update on key HIV studies anticipated to affect clinical practice.
    Date Posted: 8/4/2017
  • Key Studies Influencing My Practice Following IAS 2017

    In this downloadable slideset from a recent live Webinar, expert faculty members Anton L. Pozniak, MD, FRCP, and Kathleen E. Squires, MD, highlight key studies from IAS 2017 that are anticipated to affect clinical practice.
    Date Posted: 7/28/2017
  • NEAT 022: Switch From Boosted PI–Based ART to Dolutegravir-Based ART Maintains Virologic Suppression, Improves Lipid Profile in Virologically Suppressed Patients With High CVD Risk

    Efficacy of switch to INSTI-based regimen noninferior to continued PI treatment at Week 48 in older HIV-infected population with multiple risk factors for cardiovascular disease.
    Date Posted: 7/27/2017
  • Contemporary Management of HIV: Managing ART in HIV-Infected Patients With Common Comorbidities

    In this downloadable slideset, David A. Wohl, MD, and Program Director Joseph J. Eron, Jr., MD, review key data and offer expert guidance on managing HIV treatment in patients with frequently encountered comorbidities, including cardiovascular disease, osteopenia, and HCV coinfection.
    Date Posted: 7/19/2017
  • Choosing Statins for Patients With Dyslipidemia and Elevated CVD Risk

    David A. Wohl MD - 6/1/2017 2 comments / Last Comment: 8/16/2017
    Which statins should be avoided in patients receiving boosted ART regimens?
  • Selecting ART for an Aging Patient With Multiple Comorbidities and Potential Drug–Drug Interactions

    David A. Wohl MD - 5/31/2017 3 comments / Last Comment: 7/31/2017
    In an older patient managing hypertension, reactive airways disease, and moderate renal insufficiency, what ART regimen would you recommend?
  • Adopting Lung Cancer Screening Recommendations for an HIV-Infected Individual With a Smoking History

    David A. Wohl MD - 5/31/2017
    What qualifies an HIV-infected past or current smoker for annual lung cancer screening using low-dose CT scans?
  • ART Switch for Comorbidities in a Middle-Aged Black Woman

    Lisa Hightow-Weidman MD, MPH - 5/12/2017 1 comment / Last Comment: 6/16/2017
    One-tablet regimens may not always be the best choice of ART, but the best choice is always the one the patient is willing to take.
  • Initiating ART in a Hispanic MSM With Fear of Stigma and History of Depression

    Lisa Hightow-Weidman MD, MPH - 5/12/2017
    Understanding a patient’s life circumstances may be as important as any other aspect of providing good care.
10 of 131 Shown
Show 10 More
Loading...